litlas
ログインアカウント作成

Dara L. Aisner

1997–2026 年に発表

83
論文数
20,708
被引用数
63
h 指数
79
i10 指数

被引用数

Dara L. Aisner の年別被引用数1971 年: 被引用 1 件1990 年: 被引用 1 件1993 年: 被引用 3 件1998 年: 被引用 4 件1999 年: 被引用 24 件2000 年: 被引用 39 件2001 年: 被引用 37 件2002 年: 被引用 59 件2003 年: 被引用 36 件2004 年: 被引用 17 件2005 年: 被引用 23 件2006 年: 被引用 24 件2007 年: 被引用 18 件2008 年: 被引用 10 件2009 年: 被引用 11 件2010 年: 被引用 20 件2011 年: 被引用 15 件2012 年: 被引用 41 件2013 年: 被引用 88 件2014 年: 被引用 103 件2015 年: 被引用 149 件2016 年: 被引用 241 件2017 年: 被引用 228 件2018 年: 被引用 261 件2019 年: 被引用 948 件2020 年: 被引用 1,029 件2021 年: 被引用 997 件2022 年: 被引用 779 件2023 年: 被引用 534 件2024 年: 被引用 937 件2025 年: 被引用 378 件2026 年: 被引用 10 件1972〜1989 年は被引用が無いため表示していません1991〜1992 年は被引用が無いため表示していません1994〜1997 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,370 件、この内訳の 25.7%中国: 引用元論文 1,591 件、この内訳の 17.2%イタリア: 引用元論文 524 件、この内訳の 5.7%日本: 引用元論文 383 件、この内訳の 4.1%イギリス: 引用元論文 379 件、この内訳の 4.1%ドイツ: 引用元論文 370 件、この内訳の 4%フランス: 引用元論文 341 件、この内訳の 3.7%カナダ: 引用元論文 307 件、この内訳の 3.3%スペイン: 引用元論文 276 件、この内訳の 3%韓国: 引用元論文 268 件、この内訳の 2.9%スイス: 引用元論文 217 件、この内訳の 2.4%オランダ: 引用元論文 206 件、この内訳の 2.2%
0%25.7%その他 21.7%

機関

分野

  • Medicine72.9%
  • Biochemistry, Genetics and Molecular Biology20.8%
  • Health Professions1.4%
  • Immunology and Microbiology1%
  • Computer Science0.9%
  • Engineering0.6%
  • その他2.4%

トピック

  • Lung Cancer Treatments and Mutations15.3%
  • Lung Cancer Diagnosis and Treatment7.3%
  • Lung Cancer Research Studies6.8%
  • Cancer Genomics and Diagnostics5.5%
  • Cancer Immunotherapy and Biomarkers4.7%
  • Radiomics and Machine Learning in Medical Imaging2.2%
  • その他58.2%

共著者

全論文

検索で開く
  1. Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

    著者: David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Débora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D’Amico, Malcolm M. DeCamp, Thomas J. Dilling, Jonathan E. Dowell, Scott Gettinger, Travis E. Grotz, Matthew A. Gubens, Aparna Hegde, Rudy P. Lackner, Michael Lanuti, Jules Lin, Billy W. Loo, Christine M. Lovly, Fabien Maldonado, Erminia Massarelli, Daniel Morgensztern, Thomas Ng, Gregory A. Otterson, Jose M. Pacheco, Sandip Pravin Patel, Gregory J. Riely, Jonathan W. Riess, Steven E. Schild, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda L. Tam, Tawee Tanvetyanon, Jane Yanagawa, Stephen C. Yang, Edwin Yau, Kristina M. Gregory, Miranda Hughes - Journal of the National Comprehensive Cancer Network 2022 被引用: 1,419

  2. NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023

    著者: David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Débora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Malcolm M. DeCamp, Thomas J. Dilling, Jonathan E. Dowell, Gregory A. Durm, Scott Gettinger, Travis E. Grotz, Matthew A. Gubens, Aparna Hegde, Rudy P. Lackner, Michael Lanuti, Jules Lin, Billy W. Loo, Christine M. Lovly, Fabien Maldonado, Erminia Massarelli, Daniel Morgensztern, Thomas Ng, Gregory A. Otterson, Sandip Pravin Patel, Tejas Patil, Patricio M. Polanco, Gregory J. Riely, Jonathan W. Riess, Steven E. Schild, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda L. Tam, Tawee Tanvetyanon, Jane Yanagawa, Stephen C. Yang, Edwin Yau, Kristina M. Gregory, Miranda Hughes - Journal of the National Comprehensive Cancer Network 2023 被引用: 483

  3. Non–Small Cell Lung Cancer, Version 4.2024

    著者: Gregory J. Riely, Douglas E. Wood, David S. Ettinger, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Débora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Malcolm M. DeCamp, Aakash Desai, Thomas J. Dilling, Jonathan E. Dowell, Gregory A. Durm, Scott Gettinger, Travis E. Grotz, Matthew A. Gubens, Aditya Juloori, Rudy P. Lackner, Michael Lanuti, Jules Lin, Billy W. Loo, Christine M. Lovly, Fabien Maldonado, Erminia Massarelli, Daniel Morgensztern, Trey C. Mullikin, Thomas Ng, Dawn Owen, Dwight H. Owen, Sandip Pravin Patel, Tejas Patil, Patricio M. Polanco, Jonathan W. Riess, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda L. Tam, Tawee Tanvetyanon, Jane Yanagawa, Stephen C. Yang, Edwin Yau, Kristina M. Gregory, Lisa Hang - Journal of the National Comprehensive Cancer Network 2024 被引用: 756

  4. NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021

    著者: David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Débora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D’Amico, Thomas J. Dilling, Jonathan E. Dowell, Scott Gettinger, Matthew A. Gubens, Aparna Hegde, Mark Hennon, Rudy P. Lackner, Michael Lanuti, Ticiana Leal, Jules Lin, Billy W. Loo, Christine M. Lovly, Renato Martins, Erminia Massarelli, Daniel Morgensztern, Thomas Ng, Gregory A. Otterson, Sandip Pravin Patel, Gregory J. Riely, Steven E. Schild, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda L. Tam, Jane Yanagawa, Stephen C. Yang, Kristina M. Gregory, Miranda Hughes - Journal of the National Comprehensive Cancer Network 2021 被引用: 1,006

  5. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

    著者: Neal I. Lindeman, Philip T. Cagle, Dara L. Aisner, Maria E. Arcila, Mary Beth Beasley, Eric Bernicker, Carol Colasacco, Sanja Đačić, Fred R. Hirsch, Keith M. Kerr, David J. Kwiatkowski, Marc Ladanyi, Jan A. Nowak, Lynette M. Sholl, Robyn Temple‐Smolkin, Benjamin Solomon, Lesley Souter, Erik Thunnissen, Ming‐Sound Tsao, Christina B. Ventura, Murry W. Wynes, Yasushi Yatabe - Archives of Pathology & Laboratory Medicine 2018 被引用: 931

  6. Non–Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology

    著者: David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Lucian R. Chirieac, Thomas A. D’Amico, Malcolm M. DeCamp, Thomas J. Dilling, M.C. Dobelbower, Robert C. Doebele, Ramaswamy Govindan, Matthew A. Gubens, Mark Hennon, Leora Horn, Ritsuko Komaki, Rudy P. Lackner, Michael Lanuti, Ticiana Leal, Leah J. Leisch, Rogerio Lilenbaum, Jules Lin, Billy W. Loo, Renato Martins, Gregory A. Otterson, Karen L. Reckamp, Gregory J. Riely, Steven E. Schild, Theresa A. Shapiro, James Stevenson, Steven Swanson, Kurt W. Tauer, Stephen C. Yang, Kristina M. Gregory, Miranda Hughes - Journal of the National Comprehensive Cancer Network 2017 被引用: 1,325

  7. NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020

    著者: David S. Ettinger, Douglas E. Wood, Charu Aggarwal, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Débora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D’Amico, Thomas J. Dilling, M.C. Dobelbower, Scott Gettinger, Ramaswamy Govindan, Matthew A. Gubens, Mark Hennon, Leora Horn, Rudy P. Lackner, Michael Lanuti, Ticiana Leal, Jules Lin, Billy W. Loo, Renato Martins, Gregory A. Otterson, Sandip Pravin Patel, Karen L. Reckamp, Gregory J. Riely, Steven E. Schild, Theresa A. Shapiro, James Stevenson, Scott J. Swanson, Kurt W. Tauer, Stephen C. Yang, Kristina M. Gregory, OCN, Miranda Hughes - Journal of the National Comprehensive Cancer Network 2019 被引用: 1,005

  8. The Incidence of Brain Metastases in Stage IV ROS1-Rearranged Non–Small Cell Lung Cancer and Rate of Central Nervous System Progression on Crizotinib

    著者: Tejas Patil, Derek Smith, Paul A. Bunn, Dara L. Aisner, Anh T. Le, Mark J. Hancock, W. Thomas Purcell, Daniel W. Bowles, D. Ross Camidge, Robert C. Doebele - Journal of Thoracic Oncology 2018 被引用: 199

  9. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors

    著者: Neal I. Lindeman, Philip T. Cagle, Dara L. Aisner, Maria E. Arcila, Mary Beth Beasley, Eric Bernicker, Carol Colasacco, Sanja Đačić, Fred R. Hirsch, Keith M. Kerr, David J. Kwiatkowski, Marc Ladanyi, Jan A. Nowak, Lynette M. Sholl, Robyn Temple‐Smolkin, Benjamin Solomon, Lesley Souter, Erik Thunnissen, Ming‐Sound Tsao, Christina B. Ventura, Murry W. Wynes, Yasushi Yatabe - Journal of Molecular Diagnostics 2018 被引用: 633

  10. Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer

    著者: Andrew Weickhardt, Benjamin Scheier, Joseph Burke, Gregory N. Gan, Xian Lu, Paul A. Bunn, Dara L. Aisner, Laurie E. Gaspar, Brian D. Kavanagh, Robert C. Doebele, D. Ross Camidge - Journal of Thoracic Oncology 2012 被引用: 677

  11. HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers

    著者: Bob T. Li, Dara S. Ross, Dara L. Aisner, Jamie E. Chaft, Meier Hsu, Severine Kako, Mark G. Kris, Marileila Varella‐Garcia, Maria E. Arcila - Journal of Thoracic Oncology 2015 被引用: 278

  12. Identifying and Targeting ROS1 Gene Fusions in Non–Small Cell Lung Cancer

    著者: Kurtis D. Davies, Anh T. Le, Mariana F. Theodoro, Margaret C. Skokan, Dara L. Aisner, Eamon M. Berge, Luigi Terracciano, Federico Cappuzzo, Matteo Incarbone, Massimo Roncalli, Marco Alloisio, Armando Santoro, D. Ross Camidge, Marileila Varella‐Garcia, Robert C. Doebele - Clinical Cancer Research 2012 被引用: 472

  13. Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience

    著者: Lynette M. Sholl, Dara L. Aisner, Marileila Varella‐Garcia, Lynne D. Berry, Dora Dias‐Santagata, Ignacio I. Wistuba, Heidi Chen, Junya Fujimoto, Kelly Kugler, Wilbur A. Franklin, A. John Iafrate, Marc Ladanyi, Mark G. Kris, Bruce E. Johnson, Paul A. Bunn, John D. Minna, David J. Kwiatkowski - Journal of Thoracic Oncology 2015 被引用: 430

  14. Resistance Mechanisms to Targeted Therapies in ROS1 + and ALK + Non–small Cell Lung Cancer

    著者: Caroline E. McCoach, Anh T. Le, Katherine Gowan, Kenneth A. Jones, Laura Schubert, Andrea E. Doak, Adriana Estrada‐Bernal, Kurtis D. Davies, Daniel T. Merrick, Paul A. Bunn, W. Tom Purcell, Rafał Dziadziuszko, Marileila Varella‐Garcia, Dara L. Aisner, D. Ross Camidge, Robert C. Doebele - Clinical Cancer Research 2018 被引用: 246

  15. Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium Experience

    著者: Badi El Osta, Madhusmita Behera, Sungjin Kim, Lynne D. Berry, Gabriel Sica, Rathi N. Pillai, Taofeek K. Owonikoko, Mark G. Kris, Bruce E. Johnson, David J. Kwiatkowski, Lynette M. Sholl, Dara L. Aisner, Paul A. Bunn, Fadlo R. Khuri, Suresh S. Ramalingam - Journal of Thoracic Oncology 2019 被引用: 241

  16. DNA-Based versus RNA-Based Detection of MET Exon 14 Skipping Events in Lung Cancer

    著者: Kurtis D. Davies, Aprille Lomboy, Carolyn A. Lawrence, Michael Yourshaw, Gregary T. Bocsi, D. Ross Camidge, Dara L. Aisner - Journal of Thoracic Oncology 2019 被引用: 150

  17. RAS-MAPK dependence underlies a rational polytherapy strategy in EML4-ALK–positive lung cancer

    著者: Gorjan Hrustanovic, Victor Olivas, Evangelos Pazarentzos, Asmin Tulpule, Saurabh Asthana, Collin M. Blakely, Ross A. Okimoto, Luping Lin, Dana S. Neel, Amit J. Sabnis, Jennifer C. Flanagan, Elton Chan, Marileila Varella‐Garcia, Dara L. Aisner, Aria Vaishnavi, Sai‐Hong Ignatius Ou, Eric A. Collisson, Eiki Ichihara, Philip C. Mack, Christine M. Lovly, Niki Karachaliou, Rafael Rosell, Jonathan W. Riess, Robert C. Doebele, Trever G. Bivona - Nature Medicine 2015 被引用: 277

  18. MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation Consortium

    著者: Robin Guo, Lynne D. Berry, Dara L. Aisner, Jamie Sheren, Theresa A. Boyle, Paul A. Bunn, Bruce E. Johnson, David J. Kwiatkowski, Alexander Drilon, Lynette M. Sholl, Mark G. Kris - Journal of Thoracic Oncology 2019 被引用: 174

  19. The Learning Healthcare System: Workshop Summary

    著者: LeighAnne Olsen, Dara L. Aisner, J. Michael McGinnis - 2013 被引用: 587

  20. Identifying the Appropriate FISH Criteria for Defining MET Copy Number–Driven Lung Adenocarcinoma through Oncogene Overlap Analysis

    著者: Sinéad Noonan, Lynne D. Berry, Xian Lu, Dexiang Gao, Anna E. Barón, Patrick Chesnut, Jamie Sheren, Dara L. Aisner, Dan Merrick, Robert C. Doebele, Marileila Varella‐Garcia, D. Ross Camidge - Journal of Thoracic Oncology 2016 被引用: 170

  21. Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: A Phase II Multicenter Study

    著者: Collin M. Blakely, Anatoly Urisman, Matthew A. Gubens, Claire K. Mulvey, Greg M. Allen, Stephen Shiboski, Julia Rotow, Turja Chakrabarti, D. Lucas Kerr, Jacqueline V. Aredo, Bianca Bacaltos, Megan Gee, Lisa Tan, Kirk D. Jones, W. Patrick Devine, Robert C. Doebele, Dara L. Aisner, Tejas Patil, Erin L. Schenk, Trever G. Bivona, Jonathan W. Riess, Melissa H. Coleman, Johannes R. Kratz, David M. Jablons - Journal of Clinical Oncology 2024 被引用: 57

  22. PIK3CAMutations Drive Therapeutic Resistance in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

    著者: Aryana R. Rasti, Amy Guimaraes-Young, Farrah Mikhail Datko, Virginia F. Borges, Dara L. Aisner, Elena Shagisultanova - JCO Precision Oncology 2022 被引用: 58

  23. Mechanisms of Resistance to Crizotinib in Patients with ALK Gene Rearranged Non–Small Cell Lung Cancer

    著者: Robert C. Doebele, Amanda Pilling, Dara L. Aisner, Tatiana G. Kutateladze, Anh T. Le, Andrew Weickhardt, Kimi Kondo, Derek J. Linderman, Lynn E. Heasley, Wilbur A. Franklin, Marileila Varella‐Garcia, D. Ross Camidge - Clinical Cancer Research 2012 被引用: 1,065

  24. Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer

    著者: Aria Vaishnavi, Marzia Capelletti, Anh T. Le, Severine Kako, Mohit Butaney, Dalia Ercan, Sakshi Mahale, Kurtis D. Davies, Dara L. Aisner, Amanda Pilling, Eamon M. Berge, Jhingook Kim, Hidefumi Sasaki, Seung-Il Park, Gregory V. Kryukov, Levi A. Garraway, Peter S. Hammerman, Julia Haas, Steven W. Andrews, Doron Lipson, Philip J. Stephens, Vince A Miller, Marileila Varella‐Garcia, Pasi A. Jänne, Robert C. Doebele - Nature Medicine 2013 被引用: 602